Search research articles
Contact Us
Filters
Showing results (51-60 of 360) with videos related to
Page
of 36
Sort By:
Clinical Pharmacokinetics
|
January 1, 1977
Pharmacokinetic interactions with rifampicin
W Zilly, D D Breimer, E Richter
Journal of Chromatography
|
January 30, 1974
Rapid and sensitive gas chromatographic determination of hexobarbital in plasma of man using a nitrogen detector
D D Breimer, J M Van Rossum
Clinical Pharmacology and Therapeutics
|
May 1, 1978
Hexobarbital disposition in compensated and decompensated cirrhosis of the liver
W Zilly, D D Breimer, E Richter
European Journal of Clinical Pharmacology
|
January 1, 1980
Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents
E Richter, D D Breimer, W Zilly
European Journal of Clinical Pharmacology
|
December 19, 1975
Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance
W Zilly, D D Breimer, E Richter
Journal of the Royal College of Physicians of London
|
November 1, 1994
The blood-brain barrier: clinical implications for drug delivery to the brain
A G De Boer, D D Breimer
Clinical Pharmacology and Therapeutics
|
April 1, 1977
Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine
D D Breimer, W Zilly, E Richter
European Journal of Clinical Pharmacology
|
December 19, 1975
Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man
D D Breimer, A G de Boer
Pharmacology
|
January 1, 1982
3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance
M Danhof, M W Teunissen, D D Breimer
Biochemical Pharmacology
|
July 1, 1986
Microsomal and cytosolic epoxide hydrolase in Drosophila melanogaster
M Jansen, A J Baars, D D Breimer
Page
of 36
Search research articles
Search
Showing results (51-60 of 360) with videos related to
Sort By:
Page
of 36
Clinical Pharmacokinetics
|
January 1, 1977
Pharmacokinetic interactions with rifampicin
W Zilly, D D Breimer, E Richter
Journal of Chromatography
|
January 30, 1974
Rapid and sensitive gas chromatographic determination of hexobarbital in plasma of man using a nitrogen detector
D D Breimer, J M Van Rossum
Clinical Pharmacology and Therapeutics
|
May 1, 1978
Hexobarbital disposition in compensated and decompensated cirrhosis of the liver
W Zilly, D D Breimer, E Richter
European Journal of Clinical Pharmacology
|
January 1, 1980
Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents
E Richter, D D Breimer, W Zilly
European Journal of Clinical Pharmacology
|
December 19, 1975
Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance
W Zilly, D D Breimer, E Richter
Journal of the Royal College of Physicians of London
|
November 1, 1994
The blood-brain barrier: clinical implications for drug delivery to the brain
A G De Boer, D D Breimer
Clinical Pharmacology and Therapeutics
|
April 1, 1977
Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine
D D Breimer, W Zilly, E Richter
European Journal of Clinical Pharmacology
|
December 19, 1975
Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man
D D Breimer, A G de Boer
Pharmacology
|
January 1, 1982
3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance
M Danhof, M W Teunissen, D D Breimer
Biochemical Pharmacology
|
July 1, 1986
Microsomal and cytosolic epoxide hydrolase in Drosophila melanogaster
M Jansen, A J Baars, D D Breimer
Page
of 36